Announced
Completed
Synopsis
KKR, a global investment firm, and Hellman & Friedman, an American private equity firm, led a $90m investment in Ajax Health-backed Cortex, a medical technology company developing an integrated mapping and ablation solution suite for the treatment of atrial fibrillation, with participation from AI Life Sciences and Access Industries. "Cortex's vision is to enable more intelligent AFib treatment. We are developing solutions that prioritize precision, simplicity, and efficiency to simultaneously improve patient outcomes and lower procedural cost," Duke Rohlen, Ajax Health and Cortex CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.